← Back to Search

Behavioural Intervention

SavvyHealth App for Multiple Sclerosis (SavvyHealth Trial)

N/A
Recruiting
Led By Chungyi Chiu
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with MS
Aged 18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1 week
Awards & highlights
No Placebo-Only Group

Summary

This trial will measure how a new app can help people with multiple sclerosis manage their health.

Who is the study for?
This trial is for adults over 18 with multiple sclerosis (MS) who are willing to use a new health e-library app, SavvyHealth, and take surveys. Participants must have at least one other health condition alongside MS and be open to being randomly placed in either the intervention or control group.
What is being tested?
The study is testing the effectiveness of SavvyHealth, an individualized-health e-library app designed for people with MS. The goal is to see if using the app for three weeks can help manage their condition better than not using it.
What are the potential side effects?
Since this trial involves an informational app rather than medication, traditional physical side effects are not expected. However, participants may experience frustration or stress if they find the technology challenging.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with multiple sclerosis (MS).
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1 week
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1 week for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
MS Self-management Scale

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SavvyHealthExperimental Treatment1 Intervention
Participants will use the new app, SavvyHealth, for 21 days.
Group II: Waiting listActive Control1 Intervention
Participants will be on the waiting list.

Find a Location

Who is running the clinical trial?

University of Illinois at Urbana-ChampaignLead Sponsor
198 Previous Clinical Trials
38,455 Total Patients Enrolled
16 Trials studying Multiple Sclerosis
695 Patients Enrolled for Multiple Sclerosis
Chungyi ChiuPrincipal InvestigatorUniversity of Illinois at Urbana-Champaign

Media Library

SavvyHealth (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05124600 — N/A
Multiple Sclerosis Research Study Groups: SavvyHealth, Waiting list
Multiple Sclerosis Clinical Trial 2023: SavvyHealth Highlights & Side Effects. Trial Name: NCT05124600 — N/A
SavvyHealth (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05124600 — N/A
~2 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top